Trial intelligence / Profile preview

Naproxen Gel vs Diclofenac and Placebo in Acute Soft Tissue Injuries

NCT05026320Phase 2Completed

Sponsor
Bayer
Start
Aug 2021
Primary completion
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of naproxen in soft tissue injury, sponsored by Bayer. Started Aug 2021; status: completed.

02

Drugs

naproxen
03

Conditions

soft tissue injury

Beyond the preview

Go deeper on NCT05026320.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05026320.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call